The novel submucosal injection agent LiftUp was successfully used in a first clinical case series
The patient had experienced esophageal perforation due to bougienage with a through-the-scope balloon, which led
Ovesco is proud to announce that the gastroduodenal FTRD® has been cleared for marketing by
Conference report of the Digestive Disease Week (DDW) 2020 FTRD® System: EFTR enables new therapeutic
106 patients with perforated peptic ulcer were treated with OTSC (n = 26) or conservative
The document reviews current techniques and devices used for EFTR, clinical applications and outcomes. The
16 patients with rectovaginal fistulas, 13 of those having undergone previous surgical interventions, were treated
In lesions > 2 cm, EMR+ outdoes its advantages: comparative trial demonstrates en-bloc resection rate
Ovesco is proud to announce that LiftUp® has received market approval in Australia and New
Because of its tissue apposition capabilities and easy en face application, OTSC is used as